| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bfdeb68a360fb8cf264f4cb4e4dc9c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1a15aaad844e8195d1bee2b83e483db |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
| filingDate |
1999-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a1a206689ce0c24e3df8c460efc1520
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ebb653be021ba51c7e76b5e0700e984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed92884490277a3f6169581212044520
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42906968f45f14bb7b20197203f6b36d |
| publicationDate |
2002-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2187984-C2 |
| titleOfInvention |
Method for treating inflammatory ophthalmic diseases |
| abstract |
FIELD: medicine. SUBSTANCE: method involves introducing ozonized perfuororganic substance solution into eye cavity in 0.3-6.0 mg/l concentration in the amount of 2-3 ml. The ozonized solution is removed and substituted with physiological salt solution after exposure. EFFECT: enhanced effectiveness of treatment; prolonged ozone action. 2 cl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2392617-A |
| priorityDate |
1999-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |